ASTRAZENECA AND SINGAPORE INSTITUTIONS TO DEVELOP ANTI-CANCER COMPOUNDS
pharmaceutical companies, Friday announced it would partner with the National Cancer Centre Singapore (NCCS) and the National University Hospital (NUH) to develop anti-cancer compounds.